2025-04-12_00000114
|
ligand
|
9BBV
SARS-CoV-2 Mpro in complex with compound 6j inhibitor;
X-ray diffraction 2.46Å
Protein #1
306 residues (99% resolved)
Raw Sequence ...
SGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQ
Canonical Sequence ...
SGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQ
Non polymer #2
A1ALD
InChI=1S/C28H34N6O3/c1-17(2)13-25(28(37)31-21(15-29)14-20-11-12-30-26(20)35)32-27(36)19-9-7-18(8-10-19)22-5-4-6-24-23(22)16-34(3)33-24/h4-10,15-17,20-21,25,29H,11-14H2,1-3H3,(H,30,35)(H,31,37)(H,32,36)/b29-15+/t20-,21-,25+/m1/s1
InChI=1S/C28H34N6O3/c1-17(2)13-25(28(37)31-21(15-29)14-20-11-12-30-26(20)35)32-27(36)19-9-7-18(8-10-19)22-5-4-6-24-23(22)16-34(3)33-24/h4-10,15-17,20-21,25,29H,11-14H2,1-3H3,(H,30,35)(H,31,37)(H,32,36)/b29-15+/t20-,21-,25+/m1/s1
SMILES: CC(C)C[C@@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)C=N)NC(=O)c2ccc(cc2)c3cccc4c3cn(n4)C
CC(C)C[C@@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)C=N)NC(=O)c2ccc(cc2)c3cccc4c3cn(n4)C
Biounit #1
monomer
Download coordinates
Tube
Model
Reference
100%